Giant cell arteritis is a systemic vasculitis and careful attention should be given to the examination of the cardiovascular system including performing blood pressure measurements in both arms.

Giant cell arteritis, or GCA, is a condition where arteries in the head and neck become inflamed. It is called ‘giant cell’ because abnormally large cells accumulate in the artery walls.

Are you waking up in the morning with stiff hips, back and neck? You might want to get yourself checked for Polymyalgia Rheumatica (PMR). PMR is a condition characterized by inflammation that leads to ...

Based Performance of Inflammatory Markers in Giant Cell Arteritis,” published in the March 2025 issue of American Journal of ...

Glucocorticoid-induced adrenal insufficiency (GIAI) may be less common than previously expected, a Danish cross-sectional ...

A scientific statement regarding sex differences in patients with peripheral vascular disease has been published by the AHA.

AbbVie said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended expanded approval of its blockbuster autoimmune drug Rinvoq for the treatment of adults ...

The positive opinion is based on results from the pivotal Phase 3 SELECT-GCA trial that evaluated the efficacy and safety of upadacitinib in adults with giant cell arteritis (GCA) 1 The primary ...

Giant cell arteritis (GCA) is the most common form of vasculitis in the older adult population. There are variable clinical presentations of this entity and no perfect diagnostic test, often ...

If approved, upadacitinib would be the first and only oral advanced therapy for adults living with giant cell arteritis. RINVOQ is approved in the European Union for the treatment of adults with ...